search icon

    Market Snapshot

    • S&P Futures

      3,819

    • Dow Futures

      30,822

    • Nasdaq Futures

      11,785

    blog search icon

    Atreca, Inc.

    (NASDAQ:BCEL)

    $2.21

    $-0.02

    -0.90%

    Atreca, Inc. Chart

    BCEL Stock Price Today

    Atreca, Inc. (BCEL) stock declined over -0.90% intraday to trade at $2.21 a share on NASDAQ. The stock opened with a gain of 21.43% at $2.2 and touched an intraday high of $2.29, falling -0.90% against the last close of $2.23. The stock went to a low of $2.1 during the session.

    Stock Snapshot

    $2.23

    Prev. Close

    85.31 Million

    Market Cap

    $2.1

    Day Low

    $2.2

    Open

    37.98 Million

    Number of Shares

    $2.29

    Day High

    -

    P/E ratio

    -2.91

    EPS (TTM)

    3.10

    Cash Flow per Share

    13.02

    Free Float in %

    4.75

    Book Value

    215,709

    Volume

    Atreca, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-06$2.2$2.29$2.1$2.21215,284
    2022-07-05$1.82$2.27$1.72$2.23610,000
    2022-07-01$1.76$1.86$1.76$1.7995,700
    2022-06-30$1.83$1.86$1.76$1.79111,900
    2022-06-29$2.01$2.02$1.83$1.83175,800
    2022-06-28$1.99$2.1$1.972$2.03124,800
    2022-06-27$1.96$2.05$1.83$2.02154,700
    2022-06-24$1.91$2.18$1.9$1.963,346,500
    2022-06-23$1.73$1.93$1.71$1.93240,800
    2022-06-22$1.74$1.9$1.64$1.7433,300

    Contact Details

    835 Industrial Road
    Suite 400
    South San Francisco, CA 94070
    United States

    Webiste:BCEL

    650 595 2595

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology. Atreca, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

    Frequently Asked Questions

    icon

    What is the current Atreca, Inc. (BCEL) stock price?

    Atreca, Inc. (NASDAQ: BCEL) stock price is $2.21 as of the last check on Wednesday, July 6. During the trading session, BCEL stock reached the peak price of $2.29 while $2.1 was the lowest point it dropped to.

    icon

    BCEL's industry and sector of operation?

    The NASDAQ listed BCEL is part of Biotechnology industry that operates in the broader Health Care sector. Atreca, Inc. , a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types.

    icon

    Who are the executives of BCEL?

    Mr. John A. Orwin
    Pres, CEO & Director
    Mr. Herbert C. Cross
    Chief Financial Officer
    Dr. Tito A. Serafini Ph.D.
    Founder, Chief Strategy Officer & Director
    Dr. Yann Chong Tan
    Chief Technologist

    icon

    What is the BCEL stock price today?

    BCEL stock traded closed the last session at $2.21, which is $-0.02 or -0.90% lower than its previous close of $2.23. BCEL's current trading price is 46.36% lower than its 52-week high of $9.77 where as its distance from 52-week low of 1.51% is -77.38%.

    icon

    How many employees does BCEL have?

    Number of BCEL employees currently stands at -. BCEL operates from 835 Industrial Road, Suite 400, South San Francisco, CA 94070, United States.

    icon

    Link for BCEL official website?

    Official Webiste of $BCEL is: https://www.atreca.com

    icon

    How do I contact BCEL?

    BCEL could be contacted at BCEL operates from 835 Industrial Road, Suite 400, South San Francisco, CA 94070, United States, or at phone #650 595 2595 and can also be accessed through its website.

    icon

    How many shares of BCEL are traded daily?

    BCEL stock volume for the day was 215,709 shares while in the previous session number of BCEL shares traded was 215,284 . The average number of BCEL shares traded daily for last 3 months was 337.26 Thousands.

    icon

    How much did BCEL change today?

    The percentage change in BCEL stock occurred in the recent session was -0.90% while the dollar amount for the price change in BCEL stock was $-0.02.

    icon

    What price range BCEL stock been trading in?

    In the recent session, the day high for BCEL stock was $2.29 while the low for BCEL stock touched on the day was $2.1.

    icon

    What is the market cap of BCEL currently?

    The market value of BCEL currently stands at 85.31 Million with its latest stock price at $2.21 and 37.98 Million of its shares outstanding.